Form 4: 89bio, Inc. Executive Harry H. Mansbach Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Harry H. Mansbach, Chief Medical Officer of 89bio, Inc., reports a transaction involving the withholding of shares to cover tax obligations.
Summary
- On September 9, 2024, Harry H. Mansbach, Chief Medical Officer of 89bio, Inc., had 5,352 shares of common stock withheld to cover estimated tax obligations.
- The shares were withheld from the vesting of restricted stock units.
- Following the transaction, Mansbach directly owns 152,039 shares of 89bio, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding procedure related to vested equity.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard procedure for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/09/2024 | Date of the stock transaction (withholding of shares). |
| 09/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.